Takeshi Kawakami

13PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 29, 2026
A prospective observational study of treatment sequencing with regorafenib and FTD/TPI in metastatic colorectal cancer: The OSERO study.

|Aug 27, 2026
Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G.

|Jun 05, 2026
Impact of prior nivolumab on treatment outcomes of taxane plus ramucirumab in advanced gastric cancer.

|Feb 05, 2026
Safety and Efficacy of Concomitant Administration of Nanoliposomal Irinotecan + 5-Fluorouracil/Levo-Leucovorin for Pancreatic Cancer.

Akane Wakabayashi, Rei Tanaka, Yurie Fukumuro

|Feb 02, 2026
ANGPTL3 in the Peripheral Circulation Is Associated with Resistance to Anti-PD1 Therapy in Advanced Gastric Cancer.

Chie Kudo-Saito, Hirokazu Shoji, Kengo Nagashima

|Oct 29, 2025
Correction: Miyajima, Y.; Kawakami, T. Treatment Selection for Patients with HER2-Negative Metastatic Gastric Cancer Expressing Claudin 18.2 and PD-L1. Cancers 2025, 17, 1120.

Yusuke Miyajima, Takeshi Kawakami

Pageof 3

Frequent Collaborators

4 joint publications

Kei Muro

3 joint publications

Yusuke Miyajima

3 joint publications

Hiroki Hara

2 joint publications

Shogen Boku